Author

Nancy Redinger

Institution: Oklahoma Medical Research Foundation

Observed institution: Oklahoma Medical Research Foundation

OpenAlex ID: A5017284263

A Flare Risk Index Informed by Select Immune Mediators in Systemic Lupus Erythematosus

2022 · Melissa E. Munroe, Derek Blankenship, et al. · Arthritis & Rheumatology · 11

Peptidoglycan from Bacillus anthracis Inhibits Human Macrophage Efferocytosis in Part by Reducing Cell Surface Expression of MERTK and TIM-3

2023 · Joshua S Mytych, Zijian Pan, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2

Expediting Lupus Classification of At-risk Individuals Using Novel Technology: Outcomes of a Pilot Study

2025 · Eldon Jupe, Vijay Nadipelli, et al. · The Journal of Rheumatology · 1

Distinct IgM and IgG autoantibody profiles characterize incomplete and classified systemic autoimmune diseases

2026 · Rebecca A. Wood, Neha Kodali, et al. · Frontiers in Immunology

Persistent CD4+ T cell hyporesponsiveness during recovery from prolonged symptomatic SARS-CoV-2 infection

2026 · Jadith Ziegler, Christina Lawrence, et al. · Cellular Immunology

Persistent CD4 + T cell functional deficits during recovery from prolonged symptomatic SARS-CoV-2 infection

2025 · Jadith Ziegler, Christina Lawrence, et al. · bioRxiv (Cold Spring Harbor Laboratory)

Complementary Lupus-specific Indexes Informed by Select Immune Mediators Characterize Risk of Concurrent Disease Activity and Future Impending Flare in Systemic Lupus Erythematosus

2025 · Melissa Munroe, Daniele Defreese, et al. · The Journal of Rheumatology

Persistent CD4 T cell functional deficits in individuals recovered from prolonged symptomatic SARS-CoV-2 infection

2023 · Susan Kovats, Christina Lawrence, et al. · The Journal of Immunology

Works count: 8

Citation count: 14

H-index: 2

I10-index: 1